FOxTROT Trial The FOxTROT trial failed to reach statistical significance in risk of relapse at 2 years.
← all excerpts
2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Gastrointestinal Cancer.
1
—
—
FOxTROT Trial The FOxTROT trial failed to reach statistical significance in risk of relapse at 2 years.